Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04349956 · ClinicalTrials.gov registry record
Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo
A clinical trial, sponsored by Unity Biotechnology.
- Terminated
- Registry status
- 161
- Enrollment target
NCT04349956 is a clinical trial that was terminated before completion, run by Unity Biotechnology. The registered enrollment target is 161 participants.
The verdict
NCT04349956 was terminated before completion, sponsored by Unity Biotechnology.
- TERMINATED
- Registry status
- 161 participants
- Enrollment target
Study Summary
A follow-up study to assess the long-term safety of intra-articular (IA) administration of UBX0101 in patients with painful knee osteoarthritis (OA).
Interventions
- DRUG UBX0101 or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2020-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04349956
The ClinicalTrials.gov registry entry for NCT04349956 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Unity Biotechnology, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UBX0101 or placebo is the first listed.
NCT04349956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04349956 about?
NCT04349956 is a clinical study titled "Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo". A follow-up study to assess the long-term safety of intra-articular (IA) administration of UBX0101 in patients with painful knee osteoarthritis (OA).
What is the current status of trial NCT04349956?
This trial is currently terminated. The enrollment target is 161 participants. The study started on 2020-04-20. Estimated completion is 2020-11-02.
What interventions are being tested in trial NCT04349956?
The interventions under investigation include: UBX0101 or placebo (DRUG).
Who is sponsoring clinical trial NCT04349956?
This trial is sponsored by Unity Biotechnology, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.